Wednesday, 27 May 2020

Leronlimab May Hold Potential in Treating COVID-19

Leronlimab from CytoDyn is a promising candidate for the treatment of COVID-19 and is currently forecast by GlobalData to have peak sales of (Dollar) 747m in 2026.


from Medindia Health News https://ift.tt/2ZOvBuW

No comments:

Post a Comment